跳至主要内容
临床试验/NL-OMON52883
NL-OMON52883
招募中
4 期

A Randomized, Open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy - a strategy trial - LAX study

eids Universitair Medisch Centrum0 个研究点目标入组 110 人待定

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
Chemotherapy-induced polyneuropathy
发起方
eids Universitair Medisch Centrum
入组人数
110
状态
招募中
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Interventional

研究者

入排标准

入选标准

  • 1\. Age\> 18 years
  • 2\. Able to give oral and written informed consent
  • 3\. Presence of CIPN grade 1 or higher according to the NCIC\-CTC
  • 4\. Pain score of 4 or higher
  • 5\. Chemotherapy with taxanes, platinums, vincalkinioids or bortezomib in the
  • 6\. Presence of symptoms of neuropathic pain at least 3 months after the last
  • chemotherapy

排除标准

  • 1\. Allergy to the study medication
  • 2\. Epilepsy
  • 3\. History of illicit drug or alcohol abuse
  • 4\. History of psychosis
  • 5\. Pregnancy or lactation
  • 6\. Use of anti\-epileptic or anti\-depressant medication (in particular MAO
  • inhibitors)
  • 7\. Use of CYP1a2 inhibitors (e.g. fluvoxamine, fluocinolone, cimetidine)
  • 8\. Concomitant neuropathy other than chemotherapy\-induced
  • 9\. Moderate and severe liver enzyme abnormalities

结局指标

主要结局

未指定

相似试验